ESOMEPRAZOLE SANDOZ IV esomeprazole (as sodium) 40 mg powder for injection vial

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

esomeprazole sodium, Quantity: 42.56 mg (Equivalent: esomeprazole, Qty 40 mg)

Disponible depuis:

Sandoz Pty Ltd

DCI (Dénomination commune internationale):

Esomeprazole sodium

forme pharmaceutique:

Injection, powder for

Composition:

Excipient Ingredients: disodium edetate; nitrogen; sodium hydroxide

Mode d'administration:

Intravenous, Intravenous Infusion

Unités en paquet:

10 vials

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Esomeprazole Sandoz is indicated for the treatment of the following conditions:,The short-term management of Gastro-Oesophageal Reflux Disease (GORD) in patients with oesophagitis and/or severe symptoms of reflux as an alternative when oral therapy is inappropriate. ,Prevention of rebleeding in patients following therapeutic endoscopy for acute, bleeding gastric or duodenal ulcers.,Short-term management in patients requiring continued non-steroidal anti-inflammatory drug (NSAID) therapy when oral therapy is inappropriate:,_ healing of gastric ulcers associated with NSAID therapy,_ prevention of gastric and duodenal ulcers associated with NSAID therapy, in patients at risk

Descriptif du produit:

Visual Identification: White to almost white lyophilised powder in colourless glass vial sealed with dark gray rubber stopper and flip-off cap with white button; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Statut de autorisation:

Registered

Date de l'autorisation:

2012-03-14